I suspect that they can't deliver the revenue required. CanEpil has definitely shown some promise, but delivery of a certified drug has been a long time coming.
MXC seems to be in a situation of terminal decline. Their products are around the fringes and don't seem to attract significant orders.
Ann: First patient enrolled in MGC ZAM App CannEpil Trial, page-3
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.82M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1612 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 50 | 1 |
View Market Depth
| Last trade - 16.12pm 31/10/2024 (20 minute delay) ? |
| RGT (ASX) Chart |
Day chart unavailable